PILOT STUDY: OCTREOTIDE IN PROMOTING WEIGHT LOSS IN SERIOUS OBESITY

试点研究：奥曲肽促进严重肥胖症患者减肥

• 批准号: 6264755
• 负责人: ROBERT H LUSTIG
• 金额: $ 1.63万
• 依托单位: UNIVERSITY OF TENNESSEE HEALTH SCI CTR
• 依托单位国家: 美国
• 财政年份: 1999
• 资助国家: 美国
• 起止时间: 1999-08-16 至 1999-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6264755
• 关键词: clinical research; drug screening /evaluation; hormone therapy; human subject; human therapy evaluation; obesity; octreotide; weight control agent; weight loss

The object is to examine insulin dynamics in a group of patients with morbid obesity (BMI greater than 35), and will examine the effects of a long-acting form of octreotide on insulin suppression and weight loss in this population.

其目的是研究一组病态肥胖症患者(BMI大于35)的胰岛素动力学，并将检查一种长效形式的奥曲肽在这一人群中抑制胰岛素和减肥的效果。